William Winston, Ph.D.Vice President, Research at Werewolf Therapeutics
Dr. Bill Winston is an expert protein engineer with deep experience in the design, discovery, and preclinical development of therapeutic antibody treatments. Most recently, Dr. Winston served as Senior Director, then Vice President of Antibody Development at Potenza Therapeutics. With Potenza, he led both internal and external efforts to identify and, in partnership with Astellas, manage the contract manufacturing of a portfolio of three monoclonal antibodies that all successfully achieved IND clearances prior to the Company’s acquisition by Astellas Pharmaceuticals in 2018. Before joining Potenza, Dr. Winston was a key discovery scientist at AVEO Oncology.
Dr. Winston is a graduate of the Massachusetts Institute of Technology where he earned a B.S. in Biology, and he holds a Ph.D. in Biology from Harvard.